Listing 1 - 4 of 4 |
Sort by
|
Choose an application
The road of acceptance of oncologic thermotherapy/hyperthermia as a synergistic modality in combination with standard oncologic therapies is still bumpy. This is partially due to the lack of level I evidence from international, multicentric, randomized clinical trials including large patient numbers and a long term follow-up. Therefore we need more level I EVIDENCE from clinical trials, we need HARMONISATION and global acceptance for existing technologies and a common language understood by all stakeholders and we need INNOVATION in the fields of biology, clinics and technology to move thermotherapy/hyperthermia forward. This is the main focus of this reprint. In this reprintyou find carefully selected and peer-reviewed contributions from Africa, America, Asia, and Europe. The published papers from leading scientists from all over the world covering a broad range of timely research topics might also help to strengthen thermotherapy on a global level.
perfusion estimation --- temperature monitoring --- conductivity reconstruction --- systems medicine --- immune system in silico --- perceptron --- antigen pattern --- danger signal --- fractionation --- immune response --- head and neck cancer --- hyperthermia --- reirradiation --- treatment outcome --- hyperthermia treatment planning --- adaptive planning --- temperature optimization --- low-middle-income group countries --- cancer --- radiotherapy --- chemotherapy --- recurrent breast cancers --- cervical cancer --- head and neck cancers --- cost-effective --- meta-analysis --- intensity-modulated radiotherapy --- prostate cancer --- thermal dose --- thermometric parameters --- preclinical data --- clinical evidence --- modulated electro-hyperthermia --- abscopal effect --- locally advanced cervical cancer --- resource-constrained setting --- radiosensitiser --- rectal cancer --- chemoradiotherapy --- tumour control --- loco-regional hyperthermia --- oncology --- cellular selection --- bioelectromagnetics --- complexity --- immune-effects --- moderate hyperthermia --- deep hyperthermia --- radiative hyperthermia --- patterns of care --- reimbursement --- regional hyperthermia --- neoadjuvant chemoradiation --- survival --- induced --- brachytherapy --- prostatic neoplasms --- interstitial hyperthermia --- treatment plan optimization --- prostate --- thermoradiotherapy --- linear quadratic model --- biological modeling --- thermal dosimetry --- hypoxia --- radiation therapy --- reoxygenation --- perfusion --- oxygen consumption rate --- local tumor control --- biomarker --- immune phenotype --- hyperthermia treatment sequence --- breast cancer --- immune checkpoint molecules --- dendritic cell activation --- n/a
Choose an application
The school of thought surrounding the urban ecosystem has increasingly become in vogue among researchers worldwide. Since half of the world’s population lives in cities, urban ecosystem services have become essential to human health and wellbeing. Rapid urban growth has forced sustainable urban developers to rethink important steps by updating and, to some degree, recreating the human–ecosystem service linkage. Assessing, as well as estimating the losses of ecosystem services can denote the essential effects of urbanization and increasingly indicate where cities fall short. This book contains 13 thoroughly refereed contributions published within the Special Issue “Urban Ecosystem Services”. The book addresses topics such as nature-based solutions, green space planning, green infrastructure, rain gardens, climate change, and more. The contributions highlight new findings for landscape architects, urban planners, and policymakers. Important future cities research is considered by looking at the system connectivity between the social and ecological sphere—via varying forms of urban planning, management, and governance. The book is supported by methods and models that utilize an urban sustainability and ecosystem service-centric focus by adding knowledge-base and real-world solutions into the urbanization phenomenon.
urban planning --- urban space --- urban regeneration --- planning process --- public participation --- forest fragmentation --- sustainable development goal (SDG) --- land consumption rate to the population growth rate (LCRPGR) --- biodiversity --- non-native species --- protected species --- range expansion --- species distributions --- ecosystem services --- assessment --- urban ecosystem services --- site --- green infrastructure --- cities --- systematic literature review --- urban greenspace --- privatization --- property rights --- incremental greenspace loss --- the tyranny of small decisions --- resilience planning --- urban densification --- baseline shifts --- urban nature connection --- green spaces --- ecosystem disservices --- economic benefits --- proximity principle --- hedonic pricing analysis --- climate change --- human health, human-nature connection theory --- urbanization --- urban resilience theory --- capacity building --- municipal planning practice --- urban governance --- environmental planning --- nature-based solutions --- urban adaptive capacity --- LiDAR/NDVI --- stakeholders --- Delphi analysis --- full-scale infiltration test --- MPD infiltration test --- boreholes --- SuDS --- NBS --- flood resilience --- online climate adaptation platforms --- citizen science --- community-building --- n/a
Choose an application
With the announcement of the European Green Deal, which defines a set of policy initiatives aimed at achieving a 50–55% reduction in carbon emissions by 2030 and making Europe climate neutral in 2050, the challenge of energy transition becomes even more critical. The transformation of national energy systems towards sustainability is progressing throughout all Central and Eastern European (CEE) countries, yet the goals and results are different. Most EU Member States have made substantial progress towards meeting their long-term commitments of emissions reductions. However, some bloc members have struggled to meet their obligations. An effective energy transition requires the introduction of appropriately designed policy instruments and of robust economic analyses that ensure the best possible outcomes at the lowest costs for society. In this context, this Special Issue aims to bring into the discussion the challenges that CEE countries have to face and overcome while undergoing energy transition.
climate change --- food security --- grand challenges --- multiple factor analysis --- regional studies --- renewable energy --- sustainable development goals --- support systems --- energy policy --- cogeneration --- capacity market --- individual cogeneration premium --- trade globalization --- financial globalization --- CO2 emissions --- real GDP per capita --- bootstrap panel Granger causality --- EU transition economies --- photovoltaics --- renewable energy sources --- “My Electricity” --- renewable energy policy --- Poland --- “Mój Prąd” --- grant --- renewable energy grants --- renewable energy support --- economic appraisal --- social discount rate --- Ramsey formula --- consumption rate of interest --- social opportunity cost --- renewable energy sources (RES) --- green energy transformation --- sustainable development --- energy cooperatives --- coopetition --- Renewable Energy Communities --- management --- households --- energy consumption --- platform --- EU ETS --- CO2 --- emissions trading --- energy companies from Central and Eastern Europe --- decarbonisation --- energy transition --- low-carbon technology --- climate and energy policy --- indicators --- biomass --- electric vehicle --- electromobility --- energy balance --- efficiency engines --- clustering --- charging stations --- data analysis --- hydrogen cells --- energy law --- customer preferences --- electric car --- PHEV --- driving technique --- limestone sorbents --- flue gas desulphurisation --- FGD gypsum --- coal-fired power plants --- climate policy --- capacity adequacy --- linear programming --- COVID-19 pandemic --- lockdown --- electricity demand profiles --- Polish energy mix --- energy transition in Poland --- social acceptance --- carbon emissions --- fleet electrification --- sustainable mobility --- fleet management --- energy mix --- onshore wind --- risk assessment --- cash-flows --- discount rate --- cost of capital --- cost of equity --- district heating --- decarbonization --- energy efficiency --- Hubgrade --- remuneration mechanism --- power generation --- new investments --- combined heat and power --- optimization --- thermal energy storage --- uncertainty
Choose an application
Plants have served mankind as an important source of foods and medicines. While we all consume plants and their products for nutritional support, a majority of the world population also rely on botanical remedies to meet their health needs, either as their own “traditional medicine” or as “complementary and alternative medicine”. From a pharmaceutical point of view, many compounds obtained from plant sources have long been known to possess bio/pharmacological activities, and historically, plants have yielded many important drugs for human use, from morphine discovered in the early nineteenth century to the more recent paclitaxel and artemisinin. Today, we are witnessing a global resurgence in interest and use of plant-based therapies and botanical products, and natural products remain an important and viable source of lead compounds in many drug discovery programs.This Special Issue on “Plant Natural Products for Human Health” compiles a series of scientific reports to demonstrate the medicinal potentials of plant natural products. It covers a range of disease targets, such as diabetes, inflammation, cancer, neurological disease, cardiovascular disease, liver damage, bacterial, and fungus infection and malarial. These papers provide important insights into the current state of research on drug discovery and new techniques. It is hoped that this Special Issue will serve as a timely reference for researchers and scholars who are interested in the discovery of potentially useful molecules from plant sources for health-related applications.
PhGs --- bitter orange --- immunomodulator --- A549 cells --- bergapten --- triptolide --- BMP/Smad --- phytochemicals --- antioxidant enzymes --- kumquat --- MTT assay --- HepaRG cells --- human health --- nanoparticles --- dendritic cells --- drug discovery --- biofilm --- catechin --- antitubercular activity --- Panax notoginseng saponins --- animals --- mouse-hair growth --- A? --- curcumin --- WNT/?-catenin --- copaiba --- AD --- Plasmodium parasites --- traditional medicine --- procyanidin A2 --- PET inhibition --- rheumatoid arthritis --- cannabinoid type 1 receptor --- iridoids --- inflammatory bowel disease --- acute liver injury --- human-hair-follicle dermal papilla cells --- Neuroprotective --- dihydromyricetin --- AMPK --- thromboembolism --- ginseng --- drug design and development --- endoplasmic reticulum stress --- mitogen-activated protein kinase --- Nrf2 --- prenylated flavonoids --- inflammation --- preclinical studies --- plants --- dietary supplements --- Glycyrrhiza uralensis --- aspirin --- Tripterygium wilfordii --- P. eryngii --- reperfusion --- ethnopharmacology --- glucans --- innovation --- hpatoprotection --- hinokitiol --- phytocannabinoid --- antistaphylococcal activity --- Shh/Gli --- green tea --- sesquiterpenoids --- adjuvant-induced arthritis --- yuzu --- hepatotoxicity --- p53/Bax --- Keap1 --- nuclear factor-kappaB --- oxidative stress --- pharmacokinetic study --- cinnamamides --- toxicity --- APAP --- Astragali Radix --- computational softwares --- plant natural product --- onion --- anti-malaria activity --- lipogenesis --- bleeding time --- diterpenoids --- Penthorum chinense Pursh --- myocardial hypertrophy --- automation --- adjuvant --- grapefruit --- melanoma cell --- essential oil --- sweet orange --- Amadori rearrangement compounds --- heme oxygenase --- global health --- calorie restriction --- bergamot --- liposomes --- EGCG --- celastrol --- herb–drug interactions --- cannabigerol --- anti-inflammation --- OH· free radical --- molecular targets --- gluconeogenesis --- microbiome --- SIRT1 --- fucoidan --- heart --- PC12 cells --- acetaminophen --- omics --- time-kill assay --- arthritis --- lychee seed --- bioinformatics --- structure–activity relationship --- precision medicine --- orange petitgrain --- immune modulation --- antiproliferation --- flavonoids --- scoulerine --- oleoresin --- triterpenic acids --- Cannabis sativa --- NAFLD --- biological activity --- differentiation --- oxygen consumption rate --- mitochondrial bioenergetics --- neroli --- apoptosis --- targeted delivery --- platelet activation --- protein kinase --- heat-process --- hepatic steatosis --- hyperglycemia --- natural products --- lemon --- genistein --- neuroinflammation --- astragaloside IV --- cytoxicity --- flavonoid --- paracetamol --- medicinal plants --- insulin resistance --- resveratrol --- mandarin --- garlic --- TGF-? --- morin hydrate --- sirtuin 3 --- MMPs --- gomisin N --- lime --- Ziziphus jujuba --- antifungal activity --- ischemia --- migration --- caspases --- small molecules
Listing 1 - 4 of 4 |
Sort by
|